Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-05-22
1982-06-08
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544207, C07D25148, C07D40112, A61K 3144, A61K 3153
Patent
active
043339336
ABSTRACT:
Novel 2-amino-4-nicotinoylamino-6-halogenophenyl-s-triazines and acid addition salts thereof, possessing strong anti-inflammatory action when the phenyl group is mono- or di-halogen substituted. The compounds are formulated into pharmaceutical compositions in bulk or dosage form, and are administered to humans and animals having inflammatory conditions or disorders until the same are reduced or overcome. The novel compounds are prepared by various procedures such as reacting a benzoguanamine which is halogen-substituted with an active derivative of nicotinic acid, and recovering the 2-amino-4-nicotinoylamino-6-halogenophenyl-s-triazines thus formed.
REFERENCES:
patent: 4291162 (1981-09-01), Matsumura et al.
Aoyagi Yoshiaki
Enomoto Hiroshi
Matsumura Shingo
Shibata Yoshihisa
Ford John M.
Nippon Shinyaku Co. Ltd.
LandOfFree
Benzoguanamine derivatives, their production and pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoguanamine derivatives, their production and pharmaceutical , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoguanamine derivatives, their production and pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-552781